Professor Sir Mike Ferguson
Mike is Regius Professor of Life Sciences at the University of Dundee. He has served on the board of governors of the Wellcome Trust (2012-2021), including as deputy chair (2018-2021), and on the board of directors of Wellcome Leap (2019-2022). He also served on the board of directors of the Medicines for Malaria Venture (2012-2024). […]
Professor Sir John Burn
Professor Sir John Burn obtained a first class honours degree in human genetics and an MD with distinction from Newcastle University, where he has been Professor of Clinical Genetics since 1991. He was appointed as a consultant specialist in Newcastle in 1984 and led the regional NHS Genetics Service for 20 years. He helped to […]
Professor Maddy Parsons
Maddy did her PhD at UCL, studying roles for mechanical forces in dermal scarring. She moved to CRUK London Research Institute for her postdoctoral training, where she developed advanced imaging approaches to understand adhesion receptor signalling in cancer progression. She was awarded a Royal Society University Research fellowship to start her lab at King’s College […]
Francesca Sadler
Francesca Sadler has 20 years’ commercial experience in the drug discovery and development field. Francesca started her career as a Clinical Scientist working at the Public Health Laboratory Service (now part of Public Health England) researching meningococcal disease. Following a rewarding early career in the laboratory, Francesca moved into the commercial arena, most recently serving […]
Dr Lynne Braidwood
Lynne joined Medicines Discovery Catapult (MDC) in 2021 as part of the Business Development Team. She supports MDC’s capabilities in Cellular Sciences, Translational Imaging, and Biomarkers. In this role, Lynne collaborates with pharmaceutical companies, biotech firms, SMEs, and academic researchers, helping them develop and execute studies by leveraging MDC’s expertise, technology, and wet lab capabilities. […]
Adriana Gambardella
Adriana joined Medicines Discovery Catapult in 2023 as part of the Virtual Research and Development team to help SMEs develop their strategies and re-disk their programmes. Building on over 18 years of research experience within academia and industry (both CROs and biotech companies), working on translational research and drug discovery programmes across different disease areas, […]
Catherine Eagle
Catherine has over 10 years of experience in the biotech industry, primarily in drug discovery with a focus on immuno-oncology and translational science. Catherine has an MSc by Research in cancer cell biology from the University of Bristol. She has expertise in establishing methods to assess drug mechanism, target engagement and PD biomarkers in both […]
William Drewe
William joined Medicines Discovery Catapult (MDC) in 2021 and is a member of the Business Development Team supporting MDC’s Translational Imaging capability. In this role William works to support pharmaceutical companies, SMEs and academic researchers develop and execute pre-clinical imaging studies by connecting them with MDC’s expertise, technology and wet-lab capabilities. William has a research […]
Jonathan Thomas
Since joining Medicines Discovery Catapult in April 2022 as a Business Development Manager, Jonathan has worked with the Biomarkers team, supporting SMEs, academics, and drug discovery researchers in identifying suitable biomarkers and clinical approaches for their drug or asset development. Jonathan’s passion for innovation has led him to excel in commercial roles within the Life […]